NCT02767271View on ClinicalTrials.gov

Maximal Use of Luliconazole Cream 1% in Pediatric Participants With Moderate to Severe Tinea Pedis or Tinea Cruris

PHASE4CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

December 2, 2015

Primary Completion Date

April 27, 2016

Study Completion Date

April 27, 2016

Conditions
Tinea PedisTinea Cruris
Interventions
DRUG

Luliconazole Cream 1%

Luliconazole cream will be applied topically per schedule specified in the arms.

Trial Locations (2)

10700

Valeant Site 01, Santo Domingo

CT1100

Valeant Site 02, San Pedro Sula

All Listed Sponsors
lead

Bausch Health Americas, Inc.

INDUSTRY

NCT02767271 - Maximal Use of Luliconazole Cream 1% in Pediatric Participants With Moderate to Severe Tinea Pedis or Tinea Cruris | Biotech Hunter | Biotech Hunter